Leoch International Technology : CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBERS OF AUDIT COMMITTEE AND NOMINATION COMMITTEE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Leoch International Technology Limited

理 士 國 際 技 術 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 842)

CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND

MEMBERS OF AUDIT COMMITTEE AND NOMINATION COMMITTEE

This announcement is made by Leoch International Technology Limited (the "Company", which together with its subsidiaries, the "Group") pursuant to Rule 13.51(2) of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited (the "Listing Rules").

(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR

The board (the "Board") of directors (each a "Director") of the Company is pleased to announce that Dr. ZHU Ping ("Dr. ZHU") has been appointed as chief executive officer of Leoch Shenzhen Renewable Energy Co., Ltd., a subsidiary of the Company with effect from 16 September 2020. Accordingly, Dr. ZHU resigned as independent non-executive Director and ceased to be members of audit committee and nomination committee with effect from 16 September 2020.

Dr. ZHU had served the Board as an independent non-executive Director since October 2019, and continually provided independent opinions and objective views to the Company. Dr. ZHU will devote more time and increase his commitment and involvement in the daily operation and development of battery manufacturing business of the Group in the future.

Dr. ZHU confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.

1. APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBERS OF AUDIT COMMITTEE AND NOMINATION COMMITTEE

The Board announces that Dr. NAN Xinsheng ("Dr. NAN") has been appointed as an independent non-executive Director and a member of each of the Audit Committee and Nomination Committee of the Company with effect from 16 September 2020.

The biographical details of Dr. NAN are set out below:

Dr. NAN, aged 58, obtained a doctor degree in business administration from the Hong Kong Polytechnic University in 2006, a master degree in management jointly issued by Fudan University and Norwegian School of Management in 1999 and degree in microwave communications the Beijing Institute of Post and Telecommunications (currently known as the Beijing University of Post and Telecommunications) in 1982.

Dr. NAN served as the vice principal of Shandong School of Posts and Telecommunications from 1982 to 1995, a deputy director of Shandong Telecom Technical Assistance Center from 1995 to 1997, the secretary of the Post and Telecommunications Bureau of Rizhao City, Shandong Province from 1997 to 1999, deputy general manager of Guoxin Paging Co., Ltd. as well as chairman of Guomai Communication Co., Ltd. from 1999 to 2000. Besides, Dr. NAN served as the general manager of different departments of China United Network Communications Group Co., Ltd. from 2000 to 2018 and served as director and the chief strategy officer of Fujian Start Group Co (stock code 600734), a company listed in Shanghai Stock Exchange from 2018-2019. Since 2019, he serves as the chief strategy officer of Beijing Ifudata Information Technology Co. Ltd.

Under the terms of his service agreement with the Company, his office shall commence on 16 September 2020 for a term of three years, which is subject to termination by either party giving not less than two months' prior written notice. In accordance with the articles of association of the Company, Dr. NAN will be subject to re-election at the general meeting of the Company after his appointment. Dr. NAN is entitled to Director's fee of HK$240,000 per annum. The above emolument of Dr. ZHU has been determined by the Board with reference to the prevailing market condition, his experience, his role and responsibilities and the Company's remuneration policy. Such remuneration has been recommended by the Remuneration Committee of the Company (the "Remuneration Committee") and approved by the Board.

As at the date of this announcement, Dr. NAN is not interested in any shares of the Company (within the meaning of Part XV of the Securities and Futures Ordinance).

Save as disclosed above and as at the date of this announcement, Dr. NAN has not held any other directorships in any public companies the securities of which are listed on any securities market in Hong Kong or overseas in the past three years. He does not have any relationship with any Directors, senior management or substantial or controlling shareholders of the Company (as defined in the Listing Rules).

Dr. NAN has confirmed that he has met the independence criteria set out in Rule 3.13 of the Listing Rules. Dr. ZHU has also confirmed that, save as disclosed above, there are no other matters relating to his appointment that need to be brought to the attention of the shareholders of the Company and there is no other information that need to be disclosed pursuant to any of the requirements under Rule 13.51(2)(h) to (v) of the Listing Rules.

The Board would like to take this opportunity to express its warmest welcome to Dr. NAN in joining the Company.

By order of the Board

Leoch International Technology Limited

Mr. DONG Li

Chairman

Hong Kong, 16 September 2020

As at the date of this announcement, the executive Directors are Mr. DONG Li and Ms. YIN Haiyan and the independent non-executive Directors are Mr. CAO Yixiong Alan, Mr. LAU Chi Kit and Dr. NAN Xinsheng.